tiprankstipranks
Trending News
More News >
Iradimed Corp (IRMD)
NASDAQ:IRMD
US Market

Iradimed (IRMD) Financial Statements

Compare
177 Followers

Iradimed Financial Overview

Iradimed's market cap is currently $1.27B. The company's EPS TTM is $0.54; its P/E ratio is 55.05; and it has a dividend yield of 1.22%. Iradimed is scheduled to report earnings on February 10, 2026, and the estimated EPS forecast is $0.45. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 83.81M$ 73.24M$ 65.56M$ 53.30M$ 41.81M
Gross Profit$ 64.32M$ 56.35M$ 50.16M$ 41.28M$ 32.05M
Operating Income$ 26.15M$ 21.96M$ 20.04M$ 15.63M$ 9.82M
EBITDA$ 28.53M$ 22.78M$ 20.80M$ 16.30M$ 11.22M
Net Income$ 22.48M$ 19.23M$ 17.19M$ 12.83M$ 9.33M
Balance Sheet
Cash & Short-Term Investments$ 51.16M$ 52.23M$ 49.76M$ 57.96M$ 62.50M
Total Assets$ 108.78M$ 98.33M$ 92.16M$ 85.51M$ 82.88M
Total Debt$ 0.00$ 154.69K$ 2.04M$ 2.21M$ 2.48M
Net Debt$ -51.16M$ -52.08M$ -47.72M$ -55.76M$ -59.52M
Total Liabilities$ 14.16M$ 11.51M$ 20.74M$ 11.84M$ 10.71M
Stockholders' Equity$ 94.62M$ 86.82M$ 71.42M$ 73.67M$ 72.17M
Cash Flow
Free Cash Flow$ 17.18M$ 17.62M$ 5.46M$ 8.17M$ 10.52M
Operating Cash Flow$ 24.95M$ 25.62M$ 13.47M$ 10.04M$ 11.26M
Investing Cash Flow$ -8.42M$ -8.82M$ -8.01M$ -1.37M$ 648.24K
Financing Cash Flow$ -17.60M$ -14.34M$ -13.66M$ -12.71M$ 24.43K
Currency in USD

Iradimed Earnings and Revenue History

Iradimed Debt to Assets

Iradimed Cash Flow

Iradimed Forecast EPS vs Actual EPS